Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2021
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Public Health

Putting the bite on rabies

Erica Weir
CMAJ October 01, 2002 167 (7) 781;
Erica Weir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Background and epidemiology: Two years ago Canada experienced its first rabies-related death in 15 years. The victim was a young Quebec boy who developed symptoms 3 weeks after an unrecognized (cryptogenic) bat bite.1 In August 2002 US researchers described the March death of a 28-year-old California man2 who had killed a bat in his house but denied any direct contact; 46 people received postexposure prophylaxis (PEP). Since 1925, there have been only 22 reported deaths from rabies in Canada,3 but this low number belies the steadily increasing incidence of rabies in animals in Canada and the United States.

Figure1

Figure. Pets pose little threat in North America

Between 1000 and 1500 Canadians receive PEP for rabies exposure each year.4 Since the infection is almost invariably fatal, it is imperative that PEP be considered in every incident in which the possibility of exposure exists.

Rabies is an acute viral infection of the central nervous system (CNS) transmitted in the saliva of biting animals. Globally, rabies infection ranks about 11th in terms of mortality from infectious diseases.4 Most of these cases occur in India, southeast Asia and Africa, and result from dog bites; due to effective domestic animal vaccination programs, wild animals are the most important vectors in North America.

Infection usually occurs from a bite or, less often, through the contact of an open wound or mucous membrane with the saliva of an infected animal. The virus replicates in local muscle fibres, binds to nicotinic acetylcholine receptors in the neuromuscular junction, travels by fast axonal transport (50–100 mm/d) to the CNS, replicates in the neurons of the spinal cord and dorsal root ganglia, infects brain neurons and then spreads centrifugally along nerves to the salivary glands, skin, corneas and other organs.5 The incubation period is typically 20–90 days, although periods ranging from a few days to more than a year have been documented.5,6

Clinical management: Malaise, anorexia and nausea are early prodromal signs. Often there is a tingling and severe pruritus at the site of the bite. After 2–10 days frank neurologic signs appear. The majority of cases manifest as “classic” rabies and are characterized by periods of hyperexcitability and autonomic dysfunction (hypersalivation, piloerection, cardiac arrhythmias, priapism). It also causes “hydrophobia” — thought to result from the selective infection of neurons controlling the defensive reflexes of the airway — so that swallowing triggers prolonged diaphragmatic and inspiratory muscular contraction. About 20% of patients may present with flaccid paralysis.5

Treatment is supportive, and death almost invariably occurs within 2 weeks after symptom onset. Only a handful of cases of human survival have been documented, and all the patients reportedly had received PEP before the onset of signs or symptoms of neurologic disease.

Prevention: Physicians should consult a public health official whenever the possibility of exposure to a rabid animal arises. The newly revised Canadian Immunization Guide4 outlines recommendations for PEP in different situations. In general, all animal bites need to be washed with soap and water, irrigated with an antiviricidal agent and left open if possible. When appropriate, antibiotics and a tetanus shot should be offered. People with bites from a dog or cat known to be vaccinated against rabies do not necessarily require PEP, provided the animal is healthy and can be quarantined and observed for 10 days, and the bite does not involve the head or neck.

Bites from wild animals such as bats and raccoons are signals to initiate PEP, as is the presence of a bat found in a room where someone is sleeping unattended. (Bat bites are needle-like punctures and are very difficult to see.) Bites from other animals, including rodents, need individual consideration.

PEP of previously nonvaccinated people involves 5 doses of 1 mL of human diploid cell vaccine (HDCV). The first dose should be administered intramuscularly (deltoid in adults or anterolateral thigh in infants) as soon as possible after exposure (day 0) with subsequent doses on days 3, 7, 14 and 28. The wound should also be thoroughly infiltrated with a dose of rabies immune globulin (20 IU/kg). About 40% of HDCV recipients experience mild systemic symptoms such as headache, abdominal pain and myalgia. Allergic reactions are rare with primary vaccination, but they have been reported in 7% of people receiving a booster dose. Animal control and wildlife workers, veterinarians, hunters and travellers to endemic countries are among the candidates for pre-exposure prophylaxis.

Erica Weir CMAJ

References

  1. 1.↵
    Human rabies in Montreal, Quebec — October 2000. Can Commun Dis Rep 2000;26(24). Available: www.hc-sc.gc.ca/hpb/lcdc/publicat/ccdr/00vol26/dr2624ea.html (accessed 2002 Aug 23).
  2. 2.↵
    Human rabies — California, 2002. MMWR Morb Mortal Wkly Rep 2002;51(31):686-8.
    OpenUrlPubMed
  3. 3.↵
    Human rabies in Canada — 1924–2000. Can Commun Dis Rep 2000;26(24). Available: www .hc-sc .gc.ca/hpb/lcdc/publicat/ccdr /00vol26 /dr 2624 eb .html (accessed 2002 Aug 23).
  4. 4.↵
    Health Canada. Canadian immunization guide. 6th ed. Ottawa: Health Canada; 2002. Available: www .hc-sc.gc.ca/pphb-dgspsp/publicat/cig-gci (accessed 2002 Aug 23).
  5. 5.↵
    Jackson A. Rabies. Can J Neurol Sci 2000;27: 278-83.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Plotkin SA. Rabies. Clin Infect Dis 2000;30:4-12.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

CMAJ
Vol. 167, Issue 7
1 Oct 2002
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Putting the bite on rabies
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Putting the bite on rabies
Erica Weir
CMAJ Oct 2002, 167 (7) 781;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Putting the bite on rabies
Erica Weir
CMAJ Oct 2002, 167 (7) 781;
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Rabies after solid organ transplantation
  • Google Scholar

More in this TOC Section

  • Seasonal drinking: Let's avoid the “January effect”
  • Influenza in children
  • Latent tuberculosis: revised treatment guidelines
Show more Public Health

Similar Articles

Collections

  • Topics
    • Public health

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of the resources on this site in an accessible format, please contact us at cmajgroup@cmaj.ca.

Powered by HighWire